Search

everythinglearnresearchcommunity

for

Search:↓

Treating cystoid macular oedema in uveitis is difficult and risky.

Denosumab may cause alopecia areata.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Drug repositioning can save time and money but needs more support.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Erzhi Pill shows promise for health issues but needs better quality control and clearer usage guidelines.

The document covers various male health issues, their causes, treatments, and related conditions.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

Peperomia pellucida shows promise for developing new therapeutic drugs.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Ursolic acid may help develop new anti-inflammatory drugs by affecting immune cells.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Strontium ranelate is no longer available for treatment.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

L-Lysine may help with various health conditions, but results are inconsistent for herpes treatment and its potential in other therapies is still being explored.

Curcuma longa and Dalbergia sissoo may work well together to treat inflammation, stress, and cancer.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Diuretics can cause serious side effects and should be used carefully.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.